Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Oncology Research is Scopus-indexed (Q2, CiteScore 4.1), WoS SCIE. Published by Tech Science Press.
Checked against the index lists dated .
ISSN 0965-0407Verify ISSN ↗1555-3906Verify ISSN ↗
Publisher: Tech Science Press
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 210 / 428 | 51st | Q2 |
| Cancer Research | 153 / 233 | 34th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2002–present (also 1992–2000), best quartile Q2, CiteScore 4.1.
Oncology Research is Q2 in Oncology (rank 210 of 428) and Q3 in Cancer Research (rank 153 of 233), by CiteScore 2025.
Oncology Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.1, which places it in quartile Q2 at the 51st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.102, quartile Q1, with an H-index of 79.
Oncology Research is published by Tech Science Press. Its print ISSN is 0965-0407 and its online ISSN is 1555-3906.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Oncology Research has an h-index of 69 and a 2-year mean of 2.47 citations per paper (OpenAlex). Its Scopus CiteScore is 4.1, quartile Q2. On 2-year citations it ranks #152 of 424 Scopus journals in Oncology.
Oncology Research published 251 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from China (30.1%), Italy (13.8%) and United States (11.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 205 retracted papers are recorded (92.1 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.